TY - JOUR
T1 - Managing and preparing for emerging infectious diseases
T2 - Avoiding a catastrophe
AU - Pereira, Vijay Edward
AU - TEMOURI, YAMA
AU - PATNAIK, SWETKETU
AU - MELLAHI, KAMEL
N1 - Funding Information:
Funding for the manufacture of the batch came from the Coalition for Epidemic Preparedness Innovations (CEPI) Government of China Health Department Government of China Health Department
Publisher Copyright:
© Academy of Management Perspectives 2020.
PY - 2020
Y1 - 2020
N2 - The extent and impact of neglected diseases has been well documented in the public health and medical science literature. However, from a strategic management and organizational perspective, there is a gap in understanding the complex relationships that underpin the functioning of product development partnerships (PDPs) in managing the drug development process. This paper focuses on (a) identifying the importance of PDPs in the development of new drugs for neglected and emerging infectious diseases and (b) identifying the key stakeholders and their relationships and (levels of) dependencies in PDPs through the resource dependence lens. Our model offers a unique perspective to the strategic alliance literature not only by showing the complex interrelationships among various stakeholders but also in highlighting power, trust, and governance as key challenges. Based on our extensive analysis of the literature and the contextualization of the recent novel coronavirus epidemic as a case, we offer conclusions and reflections from a management perspective on the ability of PDPs to mitigate risks related to neglected and emerging infectious diseases.
AB - The extent and impact of neglected diseases has been well documented in the public health and medical science literature. However, from a strategic management and organizational perspective, there is a gap in understanding the complex relationships that underpin the functioning of product development partnerships (PDPs) in managing the drug development process. This paper focuses on (a) identifying the importance of PDPs in the development of new drugs for neglected and emerging infectious diseases and (b) identifying the key stakeholders and their relationships and (levels of) dependencies in PDPs through the resource dependence lens. Our model offers a unique perspective to the strategic alliance literature not only by showing the complex interrelationships among various stakeholders but also in highlighting power, trust, and governance as key challenges. Based on our extensive analysis of the literature and the contextualization of the recent novel coronavirus epidemic as a case, we offer conclusions and reflections from a management perspective on the ability of PDPs to mitigate risks related to neglected and emerging infectious diseases.
UR - http://www.scopus.com/inward/record.url?scp=85098573689&partnerID=8YFLogxK
U2 - 10.5465/AMP.2019.0023
DO - 10.5465/AMP.2019.0023
M3 - Article
AN - SCOPUS:85098573689
SN - 1558-9080
VL - 34
SP - 480
EP - 492
JO - Academy of Management Perspectives
JF - Academy of Management Perspectives
IS - 4
ER -